MA50899B1 - Compounds useful for cdk7 inhibition - Google Patents

Compounds useful for cdk7 inhibition

Info

Publication number
MA50899B1
MA50899B1 MA50899A MA50899A MA50899B1 MA 50899 B1 MA50899 B1 MA 50899B1 MA 50899 A MA50899 A MA 50899A MA 50899 A MA50899 A MA 50899A MA 50899 B1 MA50899 B1 MA 50899B1
Authority
MA
Morocco
Prior art keywords
compounds useful
cdk7 inhibition
cdk7
inhibition
novel
Prior art date
Application number
MA50899A
Other languages
French (fr)
Other versions
MA50899A (en
Inventor
David Andrew Coates
David Michael Remick
Carlos Montero
Bharvin Kumar Rameschandra Patel
Vipin Yadav
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from PCT/US2018/060025 external-priority patent/WO2019099298A1/en
Publication of MA50899A publication Critical patent/MA50899A/en
Publication of MA50899B1 publication Critical patent/MA50899B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Abstract

La présente invention concerne de nouveaux inhibiteurs de cdk7 et des compositions pharmaceutiques associées : (i), ou un sel pharmaceutiquement acceptable de ceux-ci.The present invention relates to novel cdk7 inhibitors and related pharmaceutical compositions: (i), or a pharmaceutically acceptable salt thereof.

MA50899A 2017-11-16 2018-11-09 Compounds useful for cdk7 inhibition MA50899B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382778 2017-11-16
PCT/US2018/060025 WO2019099298A1 (en) 2017-11-16 2018-11-09 Compounds useful for inhibiting cdk7

Publications (2)

Publication Number Publication Date
MA50899A MA50899A (en) 2020-09-23
MA50899B1 true MA50899B1 (en) 2022-10-31

Family

ID=60484312

Family Applications (1)

Application Number Title Priority Date Filing Date
MA50899A MA50899B1 (en) 2017-11-16 2018-11-09 Compounds useful for cdk7 inhibition

Country Status (2)

Country Link
AR (1) AR113817A1 (en)
MA (1) MA50899B1 (en)

Also Published As

Publication number Publication date
AR113817A1 (en) 2020-06-17
MA50899A (en) 2020-09-23

Similar Documents

Publication Publication Date Title
JOP20200122B1 (en) Compounds useful for inhibiting cdk7
MA43169B1 (en) Heterocyclic compounds as pi3k-gamma inhibitors
GEP20237561B (en) Protein tyrosine phosphatase inhibitors
GEP20237506B (en) Pcsk9 antagonist compounds
MA42339A1 (en) Farnesoid Receptor Modulators x
EA201691401A1 (en) INDASOLIC COMPOUNDS AS IRAK4 INHIBITORS
EA201991884A2 (en) G12C KRAS INHIBITORS
MA46337B1 (en) Pyridine compound
MA51204B1 (en) Pharmaceutical forms comprising a plasma kallikrein inhibitor
MA42776B1 (en) Compounds useful for inhibiting t-ror
EA201992542A1 (en) PHARMACEUTICAL COMPOSITION FOR LOCAL USE CONTAINING, AT LEAST, AMITRIPTILINE FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
EP4249071A3 (en) Benzoazepine analogs as inhibiting agents for bruton's tyrosine kinase
EA202193015A1 (en) CDK INHIBITORS
MX2020001531A (en) Novel heterocyclic compounds as cdk8/19 inhibitors.
MX2018001979A (en) (s,e)-3-(6-aminopyridin-3-yl)-n-((5-(4-(3-fluoro-3-methylpyrroli dine-1-carbonyl)phenyl)-7-(4-fluorophenyl)benzofuran-2-yl)methyl )acrylamide for the treatment of cancer.
MX2019001781A (en) Condensed thiophene derivatives useful as napi-iib inhibitors.
MA43913B1 (en) Positive allosteric modulators of the m1 muscarinic receptor
MA40366A (en) TETRAHYDROQUINOLINE DERIVATIVES AS BROMODOMA INHIBITORS
MA46039B1 (en) Triazolopyrazinone derivative useful as an inhibitor of human pde1
MA50899B1 (en) Compounds useful for cdk7 inhibition
MA44383B1 (en) A derivative of 4- (3-pyrazolylamino) -benzimidazole as a jak1 inhibitor for the treatment of cancer
PH12021550258A1 (en) Cdk8/19 inhibitors
JOP20210226A1 (en) Pharmaceutical composition comprising benzimidazole derivative compound
MA50561B1 (en) btk inhibitor compounds
EA202190339A1 (en) PYRIDOPYRIMIDINES AS INHIBITORS OF H4-HISTAMINE RECEPTORS